DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.74

EPS Forecast

$14.72

Revenue Forecast

Announcing earnings for the quarter ending 2025-12-31T00:00:00 soon
NVAXNovavax IncNBIXNeurocrine Biosciences IncRGENRepligen CorpTECHBio-techne CorpCRSPCrispr Therapeutics AgMRNAModerna IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group Inc